These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7784271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
    Kwon ED, Loening SA, Hawtrey CE.
    J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
    Merrick GS, Butler WM, Galbreath RW, Lief JH.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):41-8. PubMed ID: 11516849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate.
    Stokes SH, Real JD, Adams PW, Clements JC, Wuertzer S, Kan W.
    Int J Radiat Oncol Biol Phys; 1997 Jan 15; 37(2):337-41. PubMed ID: 9069305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interstitial gold and external beam irradiation for prostate cancer.
    Boileau MA, Dowling RA, Gonzales M, Handel PH, Benson GS, Corriere JN.
    J Urol; 1988 May 15; 139(5):985-8. PubMed ID: 3129584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    Stromberg J, Martinez A, Benson R, Garton G, Diokno A, Gonzalez J, Zincke H, Schray M, Edmundson G, Brabbins D.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):67-75. PubMed ID: 8270460
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adenocarcinoma of the prostate: radioactive gold seed implant plus external irradiation.
    Gutierrez AE, Merino OR.
    Int J Radiat Oncol Biol Phys; 1988 Dec 01; 15(6):1317-22. PubMed ID: 3143692
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
    Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ.
    Cancer; 1998 Sep 01; 83(5):989-1001. PubMed ID: 9731904
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.